Botswana Blood Products Import Market -- HS Code 3002 Trade Data & Price Trend (Q2 2025)

Botswana Blood Products Import (HS 3002) Key Takeaways

Botswana's Blood Products import under HS Code 3002 in Q2 2025 was dominated by bulk veterinary vaccines, with 90% of volume but only 40% of value, reflecting a low-margin, high-volume trade. The market showed sharp volatility, declining to $757K in June amid U.S. tariff hikes, while supplier concentration reached extreme levels—a single group controlled 98% of import value. Geographic reliance on South Africa for 83% of weight exposes supply chain risks, despite premium products coming from the UK and Ireland. This analysis, covering Q2 2025, is based on cleanly processed Customs data from the yTrade database.

Botswana Blood Products Import (HS 3002) Background

What is HS Code 3002?

HS Code 3002 covers human and animal blood products, vaccines, toxins, and cultures. These products are critical for pharmaceuticals, healthcare, and research industries, driving consistent global demand due to their essential role in medical treatments and diagnostics. Botswana's blood products import under this code reflects its reliance on these materials for public health and veterinary applications.

Current Context and Strategic Position

On 2 April 2025, the U.S. Administration increased additional duties on all imports from Botswana to 37%, effective immediately [Global Trade Alert]. This policy shift could disrupt Botswana's blood products import, particularly if supply chains rely on U.S.-linked intermediaries. Given Botswana's strategic dependence on these imports for healthcare infrastructure, monitoring trade data under HS Code 3002 is essential to assess potential cost impacts and sourcing alternatives. Vigilance is warranted to navigate this evolving trade landscape.

Botswana Blood Products Import (HS 3002) Price Trend

Key Observations

Botswana's Blood Products import trend in Q2 2025 reached a total value of approximately 3.5 million USD, with unit prices fluctuating between $91.36/kg and $143.34/kg. The quarter concluded with a significant downturn in June, where imports fell to 757.21K USD, highlighting heightened volatility.

Price and Volume Dynamics

The hs code 3002 value trend built upon a strong March peak of 3.86M USD before declining sequentially through Q2, with a brief uptick in May failing to offset the overall drop. This volatility aligns with the U.S. duty increase on imports from Botswana effective April 9, as reported by [Global Trade Alert], which likely introduced trade disruptions and uncertainty, affecting medical supply chains typical for blood products. The downward momentum into June suggests continued market adjustment to these policy shifts.

Botswana Blood Products Import (HS 3002) HS Code Breakdown

Product Specialization and Concentration

In Q2 2025, Botswana's import activities under HS Code 3002 are heavily concentrated in veterinary vaccines and similar products, specifically the sub-code for vaccines for veterinary medicine. According to yTrade data, this product accounts for over 90% of the weight and 40% of the value, with a unit price of $52.65 per kilogram, indicating a focus on high-volume, lower-value goods. Extreme price anomalies are present in sub-codes like blood fractions for retail and other high-unit-price items, which are isolated from the main analysis pool due to their significantly higher costs per kilogram.

Value-Chain Structure and Grade Analysis

The non-anomalous imports under Botswana's HS Code 3002 can be grouped into bulk veterinary products, standard blood fractions, and low-value cell cultures. This structure, with predominantly low unit prices and high volume shares, suggests a trade in fungible bulk commodities rather than differentiated manufactured goods, as most items are raw or semi-processed materials without significant value addition.

Strategic Implication and Pricing Power

For market players involved in Botswana's HS Code 3002 import, the dominance of bulk commodities implies limited pricing power, necessitating a strategic focus on cost efficiency and volume management. Analyzing HS Code 3002 trade data reveals opportunities in niche, high-value segments, but the overall market favors suppliers with scale and low-cost operations.

Table: Botswana HS Code 3002) Breakdown Details (Source: yTrade)

Check Detailed HS Code 3002 Breakdown

Botswana Blood Products Import (HS 3002) Origin Countries

Geographic Concentration and Dominant Role

In Q2 2025, Botswana's imports of Blood Products under HS Code 3002 were heavily concentrated, with SOUTH AFRICA as the dominant origin. SOUTH AFRICA accounted for 30.64% of the import value but a much higher 82.61% of the weight, indicating a focus on bulk or lower-end variants, such as raw blood materials. The high frequency share of 45.43% suggests frequent shipments, likely due to the perishable nature of these goods requiring regular supply.

Origin Countries Clusters and Underlying Causes

The import origins can be grouped into two main clusters based on trade patterns. The High-Yield Cluster includes the UNITED KINGDOM and IRELAND, where value shares are high (22.40% and 21.13% respectively) but weight shares are low (1.98% and 0.34%), pointing to imports of premium or specialized Blood Products. The Volume Cluster is led by SOUTH AFRICA, with its dominant weight share reflecting its role as a primary source for bulk shipments. The UNITED STATES forms a Transactional Cluster with a frequency share of 16.04%, indicating regular, smaller consignments that support just-in-time logistics for Blood Products.

Forward Strategy and Supply Chain Implications

Botswana's heavy reliance on SOUTH AFRICA for Blood Products imports creates supply chain risks, such as potential disruptions. To enhance stability, diversifying sources towards high-yield partners like the UK and Ireland could reduce dependency. The news context provided does not offer direct support for shifts in these import patterns, so no external factors are integrated into this analysis.

Table: Botswana Blood Products (HS 3002) Top Origin Countries (Source: yTrade)

Get Complete Origin Countries Profile

Botswana Blood Products (HS 3002) Suppliers Analysis

Supplier Concentration and Dominance

In Q2 2025, the Botswana Blood Products Import suppliers market shows extreme concentration. According to yTrade data, a single group of suppliers handling high-value and high-frequency shipments dominates, accounting for 97.92% of the total import value. This group also represents 85.30% of shipment frequency, indicating that the typical trade involves regular, large-scale deliveries of blood products into Botswana.

Strategic Supplier Clusters and Trade Role

The only other active cluster consists of low-value but high-frequency suppliers, such as DUKE UNIVERSITY and LIONELS VETERINARY SUPPLIES, contributing just 2.08% to the value share. The dominant suppliers, including ROCHE and IRVINE'S AFRICA PTY LTD, point to a direct-to-factory commercial persona, as ROCHE is a known manufacturer, suggesting minimal intermediation in the supply chain for HS code 3002.

Sourcing Strategy and Vulnerability

For importers in Botswana, the heavy reliance on a few high-value suppliers creates vulnerability to supply disruptions. Strategic focus should include exploring diversification to reduce dependency. Additionally, monitoring trade policy changes is crucial, as tariff adjustments like those noted in [BURS] could impact import costs and availability. (BURS)

Table: Botswana Blood Products (HS 3002) Top Suppliers List (Source: yTrade)

Check Full Blood Products Supplier lists

Action Plan for Blood Products Market Operation and Expansion

• Diversify sourcing beyond South Africa by targeting high-yield suppliers in the UK and Ireland using hs code 3002 trade data to identify partners, reducing vulnerability in the Blood Products supply chain and securing higher-margin goods.
• Negotiate bulk purchase agreements with dominant suppliers like ROCHE to leverage volume discounts, as the Botswana Blood Products Import market is driven by scale, which will lower the average unit cost for bulk veterinary products.
• Monitor shipment frequency from key suppliers to align inventory cycles with delivery schedules, preventing stockouts or overstock of perishable Blood Products and optimizing working capital.
• Develop contingency plans for supply disruptions by pre-qualifying alternative suppliers from the transactional cluster (e.g., US-based), ensuring continuity in the Blood Products supply chain during geopolitical or logistical crises.
• Analyze unit price anomalies in niche sub-codes like retail blood fractions for potential high-value opportunities, using detailed hs code 3002 trade data to diversify into specialized segments and improve overall margin structure.

Take Action Now —— Explore Botswana Blood Products Import Data

Frequently Asked Questions

Q1. What is driving the recent changes in Botswana Blood Products Import 2025 Q2?

The Q2 2025 downturn in Botswana's Blood Products imports, including a June drop to $757.21K, reflects volatility linked to U.S. duty increases and supply chain adjustments. The market is dominated by bulk veterinary vaccines, which are sensitive to cost fluctuations.

Q2. Who are the main origin countries of Botswana Blood Products (HS Code 3002) 2025 Q2?

South Africa leads with 30.64% of import value and 82.61% of weight, followed by the UK (22.40%) and Ireland (21.13%), which specialize in high-value, low-volume shipments.

Q3. Why does the unit price differ across origin countries of Botswana Blood Products Import?

Price differences stem from product specialization: South Africa supplies bulk veterinary vaccines at $52.65/kg, while the UK and Ireland export premium blood fractions with higher unit prices.

Q4. What should importers in Botswana focus on when buying Blood Products?

Importers should diversify suppliers to reduce reliance on South Africa’s bulk shipments and explore high-yield partners like the UK and Ireland to mitigate supply chain risks.

Q5. What does this Botswana Blood Products import pattern mean for overseas suppliers?

Suppliers from high-value clusters (e.g., UK, Ireland) have opportunities to expand premium exports, while bulk-focused suppliers like South Africa must prioritize cost efficiency to maintain dominance.

Q6. How is Blood Products typically used in this trade flow?

Botswana primarily imports raw or semi-processed veterinary vaccines and blood fractions, with over 90% of volume being low-value bulk commodities for medical or agricultural use.

Detailed Monthly Report

Botswana HS3002 Import Snapshot 2025 APR

Botswana HS3002 Import Snapshot 2025 MAY